Reporter brief
Earlier menopause and higher parity associated with increased epigenetic age in meta-analysis of 29 studies
What happened
A meta-analysis of 29 studies (550,550 female participants) examined associations between reproductive history and DNA methylation clocks, which estimate epigenetic age acceleration. Earlier age at menopause was significantly associated with higher epigenetic age (β=−0.08 years per year earlier for GrimAge), and higher parity was associated with increased epigenetic age (β=0.13 years per delivery for PhenoAge). Age at menarche showed no consistent relationship with epigenetic age across clock types.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Meta analysis; Human.
29 studies of female participants (100% female) with median mean age 35.4 years (IQR: 30.3-62.7)
- Design
- Meta analysis
- Sample
- 550,550
- Journal
- Mechanisms of ageing and development
- Published
- Sep 14, 2026
Effect size
For age at menopause and GrimAge: β=-0.08 years per one-year earlier menopause (95% CI: -0.11, -0.05, n=5920). For parity and PhenoAge: β=0.13 years per delivery (95% CI: 0.04, 0.21, n=4508)
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Mixed findings across studies for age at menarche, pregnancy complications, and adverse birth outcomes. No relationship found between age at menarche and EAA in any DNAm clocks
Previous evidence
See the Epigenetic clocks timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.